Interaction of meloxicam with cimetidine, Maalox, or aspirin

Journal of Clinical Pharmacology

Volumn 36, Issue 1, 1996, Pages 79-84

  Busch, Ulrich ^a   Heinzel, Gunther ^a   Narjes, Hans ^a   Nehmiz, Gerhard ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM MAGNESIUM HYDROXIDE; CIMETIDINE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; UH AC 62XX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TOLERABILITY; DYSPEPSIA; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STOMACH EROSION;

EID: 0030023967     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04155.x     Document Type: Article

References (23)

1. Henry DA: Side effects of nonsteroidal antiinflammatory drugs. Baillieres Clin Rheumatol 1988;2:425-454.
2. Bjarnason I, Zanelli G, Prowse P, Smethurst P, Smith T, Sassoon L, et al: Blood and protein loss via small intestinal inflammation induced by nonsteroidal antiinflammatory drugs. Lancet 1987,2: 711-714.
3. Engelhardt G, Homma D, Schlegel K, Schnitzler CHR: Antiinflammatory, analgesic, and related properties of meloxicam, a new nonsteroidal antiinflammatory agent with favorable GI tolerance. Inflamm Res 1995;44:423-433.
4. Stei P, Kruss B, Wiegleb J, Trach V: Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration (data on file). Ingelheim, Germany: Boehringer Ingelheim; 1993.
5. Engelhardt G: Meloxicam, a potent inhibitor of COX-2 (abstract 82P). Presented at the Ninth International Conference on Prostaglandins and Related Compounds, June 6-10, 1994, Florence, Italy.
6. Türck D, Busch U, Heinzel G, Narjes H, Nehmiz G: Effect of food on the pharmacokinetics of meloxicam after oral administration. Clin Drug Invest 1995;9:270-276.
7. 14C-labelled meloxicam: a new antiphlogistic drug in man (abstract). In, Abstracts of the XVIIth ILAR Conference of Rheumatology. Campinas, Brazil: Brazilian Society of Rheumatology: 1989;190P.
8. Price AH, Fletcher M: Mechanisms of NSAID-induced gastroenteropathy. Drugs 1990;40(Suppl 5):1-11.
9. Wistanley PA, Orme ML: Effects of food on drug bioavailability. Br J Clin Pharmacol 1989;28:621-628.
10. Tonkin AL, Wing LMH: Interactions of nonsteroidal antiinflammatory drugs. Baillieres Clin Rheumatol 1988;2:455-483.
11. Busch U: Fully automated HPLC method for the quantitation of UH-AC 62 XX after direct injection of human plasma (data on file). Ingelheim, Germany: Boehringer Ingelheim; 1989.
12. Heinzel G, Woloszczak W, Thomann P: TopFit Version 2.0: Pharmacokinetic and Pharmacodynamic Data Analysis System. Stuttgart, Germany: Gustav Fischer Verlag, 1992.
13. Gibaldi M: Biopharmaceutics and Clinical Pharmacokinetics. Fourth edition. Philadelphia: Lea and Febiger, 1991.
14. Vane J: Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature (New Biol) 1971;231: 232-235.
15. Kimmey MB: NSAID, ulcers and prostaglandins. J J Rheumatol 1992;19(Suppl 36):68-73.
16. Wynne HA, Rawlins MD: Are systemic levels of nonsteroidal antiinflammatory drugs relevant to acute upper gastrointestinal haemorrhage? Eur J Clin Pharmacol 1993;44:309-313.
17. Rainsford KD: Mechanisms of gastrointestinal toxicity of non-steroidal antiinflammatory drugs. Scand J Gastroenterol Suppl 1989;24:9-16.
18. Langman MJS: Treating ulcers in patients receiving antiarthritic drugs. Q J Med 1989;73:1089-1091.
19. Said SA, Foda AM: Influence of cimetidine in the pharmacokinetics of piroxicam in rat and man. Drug Res 1989;39:790-792.
20. 2 receptor antagonists (abstract). Gastroenterology 1991;100:A13.
21. Gibaldi M: Stereoselective and isozyme-selective drug interactions. Chirality 1993;5:407-413.
22. Türck D, Busch U, Heinzel G, Narjes H: Clinical pharmacokinetics of meloxicam. Eur J Rheumatol Inflamm 1995;15:23-30.
23. Hobbs DC, Twomey TM: Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J Clin Pharmacol 1979,19: 270-281.